Media Center
Our industry experts, business perspectives and insights are regularly published in prominent news publications.
Home / Media Center
Featured News Releases
TRINITY LIFE SCIENCES UNVEILS BREAKTHROUGH AI MODEL THAT DETECTS TYPE 1 DIABETES A YEAR BEFORE SYMPTOMS APPEAR
July 17, 2025
TRINITY LIFE SCIENCES UNVEILS CRITICAL INSIGHTS FOR NAVIGATING THE PATH FROM INITIAL GENERATIVE AI ADOPTION TO FULL-SCALE TRANSFORMATION
June 4, 2025
TRINITY LIFE SCIENCES EXPANDS DATA PARTNERSHIP NETWORK TO REVOLUTIONIZE COMMERCIALIZATION IN COMMUNITY ONCOLOGY
May 29, 2025
Trinity in the News
pharmaphorum
Health equity can be a competitive advantage: What pharma leaders need to know
May 7, 2025
Fierce Pharma
Argenx’s Vyvgart tops Trinity’s latest launch success analysis, beating out several Big Pharma debuts
March 12, 2025
Industry Impact Series
Trinity Life Sciences is proud to announce our Industry Impact Series, a thought leadership series that identifies key issues that will revolutionize the way therapeutics are developed and commercialized in the years ahead. The focus of Trinity’s Industry Impact Series explores how biopharma can reimagine the blockbuster and translate scientific innovation to commercial success. The series is designed to leverage the totality of Trinity’s background as a life sciences partner supporting strategy, insights and analytics across the product lifecycle.
Trending at Trinity
Our Latest Intelligence
Briefs
2025 Annual State of Learning & Development in Life Sciences
Through the 2020s, life sciences leaders have dealt with one challenge after another. The shock of the COVID-19 pandemic. Sticky inflation. Return-to-office mandates. The intense pressure to perform in the face of disruptive challenges has proven constant. For commercial learning and development, also known as commercial L&D, this has presented new roadblocks and innovations alike, […]
Read More
Briefs
Leading the Evolution: Navigating AI and Pharma Market Trends
How are Commercial, Medical and Market Access organizations evolving to develop capabilities and accelerate innovation in 2025 and beyond? Executive leaders are focused on making informed organizational decisions to propel the evolution of capabilities in this rapidly changing global economy. As you strategize to optimize structure, talent and capabilities to excel in the future, this Advisory Brief brings you critical insights gleaned from the recent TGaS Advisors’ 2025 Spring Summit.
Read More
Webinars
Part D in Peril: The Inconvenient Math of IRA Part D Redesign
August 14, 2025 | 12:00 – 12:45 PM ET
Medicare Part D is undergoing its most significant transformation in decades largely driven by the IRA. What does this mean for pharmaceutical manufacturers? Join us for an engaging discussion with Max Hunt, Partner at Trinity, and special guest Dan Simenc, clinical and actuarial expert at Milliman, as they provide perspectives on recent developments and future expectations for Medicare Part D and Medicare Advantage.
Sign Up Now
Media Resources
Logos
Brand Guidelines
Trinity One-Pager
Media Contact
Richard Lorenzen
Fifth Avenue Brands
rlorenzen@fifthavenuebrands.com